The U.K. Competition and Markets Authority (CMA) announced on June 20, 2025, that it has opened a consultation on undertakings offered by SLB and ChampionX. These undertakings aim to address the CMA's competition concerns regarding the proposed $7.8 billion takeover deal.
The proposed remedies include the agreement by the parties to sell Schlumberger's production chemicals technologies and ChampionX's subsidiary US Synthetic Corporation. This indicates a willingness by both companies to make concessions to secure regulatory clearance for the merger.
The CMA has invited interested parties to comment on these proposed undertakings, with a final decision on the deal expected by July 4. The consultation process is a critical step in the regulatory review, signaling progress towards a potential resolution and completion of the merger.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.